Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II —An Updated Analysis of SEER-Medicare Data
ConclusionThe rising economic burden of RCC was most pronounced among patients with distant-stage RCC, and driven primarily by new cancer drugs.
Source: PharmacoEconomics - Category: Health Management Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Epidemiology | Health Management | Kidney Cancer | Medicare | Renal Cell Carcinoma | Study